The irreversible γ-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome [1]

Alcohol and Alcoholism

Volumn 31, Issue 1, 1996, Pages 109-111

  Stuppaeck, C H ^a   Deisenhammer, E A ^a   Kurz, M ^a   Whitworth, A B ^a   Hinterhuber, H ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID A RECEPTOR; CHLORIDE CHANNEL; LIVER ENZYME; OXAZEPAM; VIGABATRIN;

ADULT; ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SEIZURE; WITHDRAWAL SYNDROME;

EID: 0030009261     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.alcalc.a008107     Document Type: Letter

References (0)